|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Obesity | |||||
| Diabetes Mellitus | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Weight Loss | |||||
| 3 | More general conditions related to this trial | ||||
| Body Weight | |||||
| Body Weight Changes | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| Nutrition Disorders | |||||
| Overnutrition | |||||
| Overweight | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Low carbohydrate ketogenic diet | |||||
| Orlistat plus a low-fat diet | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Orlistat | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Obesity Agents | |||||
| Central Nervous System Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Department of Veterans Affairs | |||||